Premium
Monopar Therapeutics Inc (MNPR)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mu... Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.6 | -8.51063829787 | 30.55 | 32.29 | 27.05 | 32150 | 29.90778087 | CS |
| 4 | -24.17 | -46.373752878 | 52.12 | 52.25 | 27.05 | 44718 | 37.94385541 | CS |
| 12 | 1.11 | 4.13561847988 | 26.84 | 54.3 | 21 | 60482 | 34.88108311 | CS |
| 26 | 25.55 | 1064.58333333 | 2.4 | 54.3 | 2.4 | 681314 | 13.90696385 | CS |
| 52 | 23.7255 | 561.61675938 | 4.2245 | 54.3 | 1.719 | 407813 | 12.07741554 | CS |
| 156 | 13.2 | 89.4915254237 | 14.75 | 54.3 | 1.3695 | 722284 | 6.13214006 | CS |
| 260 | -16.95 | -37.7505567929 | 44.9 | 85.05 | 1.3695 | 462997 | 8.30949099 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
